Nkarta Presents Data Supporting Engineered NK Cell Based
Improved Anti-Tumor Activity Demonstrated by the Combination of NKX019 and a CD20-directed Monoclonal Antibody in Preclinical Models Pulsed Stimulation of...
James Trager Exchange Commission Society For Immunotherapy Of Cancer Nkarta Inc Improved Anti Tumor Activity Demonstrated Monoclonal Antibody
Source: globenewswire.com